News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ReNeuron And CHEMICON International, Inc. (SERO) Enter Into Agreement For Exclusive Sale And Marketing Of ReNcell Neural Stem Cell Lines


4/18/2006 1:41:48 PM

ReNeuron Group plc (LSE: RENE.L) today announces that it has signed an agreement with Chemicon International, Inc. ('Chemicon'), a subsidiary of Serologicals Corporation (NASDAQ/NM: SERO), whereby Chemicon will exclusively manufacture and distribute two of ReNeuron's patented ReNcell neural stem cell lines worldwide for research purposes.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES